Skip to main content

Table 2 Serum paraoxonase activity and biochemical parameters in small cell lung cancer adenocarcinoma and epidermoid carcinoma patient groups

From: Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population

  SCLC (n = 9) AC (n = 14) EC (n = 16) P value
Total cholesterol (mg/dl) 158.9 ± 30.7 170.9 ± 45.6 163.5 ± 63.1 0.849
LDL cholesterol (mg/dl) 115.4 ± 26.3 118.2 ± 41.1 114.4 ± 52.1 0.971
HDL cholesterol (mg/dl) 30.3 ± 4.3 34.2 ± 9.9 38 ± 31.3 0.680
VLDL cholesterol (mg/dl) 33.9 ± 15 27.8 ± 8.7 28.1 ± 11.6 0.504
Triglyceride (mg/dl) 158.8 ± 68.8 131.4 ± 37.1 140.1 ± 58.2 0.395
PON1 (U/mL) 233.9 ± 70.5 273.1 ± 118.1 245.4 ± 110.5 0.649
ARE (U/L) 163 ± 69.5 115.7 ± 44.2 142 ± 57.2 0.144
PON1/ARE 1.7 ± 0.9 2.5 ± 0.9 1.8 ± 0.7 0.062
  1. Values are mean ± S.D. SCLC:Small Cell carcinoma, AC: Adenocarcinoma, EC:Epidermoid carcinoma, PON1: paraoxonase, ARE: arylesterase